Iyuno Expands So Paulo Facility to Strengthen Global Network and Inspire Creativity
The 1,355-square-meter facility joins recent U.S. and Mexico renovations, blending cutting-edge technology…
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
SALT LAKE CITY and BOSTON, Sept. 23, 2025 /PRNewswire/ -- Myriad Genetics (Nasdaq: MYGN),…
JNH PRESS Holds Completion Ceremony for Second Plant, Accelerating Leadership in Global Innovative Press Technology
SEOUL, South Korea, Sept. 26, 2025 /PRNewswire/ -- JNH PRESS, a leading…
Hettich Unveils Campaign Highlighting its Range of Sliding Solutions
MUMBAI, India, Sept. 24, 2025 /PRNewswire/ -- Hettich, one of the world's…
LifeSpan Portfolio Company Remedium Signs Landmark Deal with Eli Lilly
NORWALK, Conn., Sept. 23, 2025 /PRNewswire/ -- Lifespan Vision Ventures is pleased…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Huawei Unveils Xinghe AI Campus Full-Scope Security Solution, Pioneering a New Paradigm for Campus Protection in the AI Era
SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- During HUAWEI CONNECT 2025, Huawei unveiled…